Sunovion Pharmaceuticals said today that the FDA accepted the revised new drug application for its eFlow chronic obstructive pulmonary disease drug-device combo.
The submission follows a complete response letter that the FDA issued Sunovion in May. The Marlborough, Mass.-based company didn’t provide details as to why the FDA denied its initial application.
Get the full story at our sister site, Drug Delivery Business News.
The post Sunovion seeks FDA nod for COPD treatment – again appeared first on MassDevice.
from MassDevice http://ift.tt/2t8V6oI
Cap comentari:
Publica un comentari a l'entrada